Ronald Martell — SPARQNOW

At-a-Glance

Exploring opportunities with public and private biopharmaceutical companies looking to advance their pipelines and maximize their potential across the healthcare industry.
Founded five companies, including Indapta Therapeutics, Orca Bio, and Encellin.
Served as CEO of three public biopharmaceutical companies: Jasper Therapeutics, Sevion, and NeurogesX.
Oversaw billions of dollars in industry transactions.
Instrumental in building ImClone Systems' worldwide operations to market and commercialize Erbitux® and Genentech's oncology franchise, including the launch of Herceptin® and Rituxan®.
Served on the boards of directors of several companies.

Biography

Ronald Martell is a veteran biopharmaceutical executive and serial entrepreneur. He has founded five companies and served on the boards of directors of several others. Most recently, he was CEO of Jasper Therapeutics, a biotechnology company focused on immunologic diseases associated with mast cells and hematopoietic cell transplant therapies. Prior to Jasper, he served as President and CEO of MorphImmune, Inc.